Erratum: PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.aaa4442)

A. Bosch, Z. Li, A. Bergamaschi, H. Ellis, E. Toska, A. Prat, J. J. Tao, D. E. Spratt, N. T. Viola-Villegas, P. Castel, G. Minuesa, N. Morse, J. Rodón, Y. Ibrahim, J. Cortes, J. Perez-Garcia, P. Galvan, J. Grueso, M. Guzman, J. A. KatzenellenbogenM. Kharas, J. S. Lewis, M. Dickler, V. Serra, N. Rosen, S. Chandarlapaty, M. Scaltriti, J. Baselga

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

In the Research Article “PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer,” the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Original languageEnglish (US)
Article numbereaav7516
JournalScience translational medicine
Volume10
Issue number464
DOIs
StatePublished - Oct 24 2018

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.aaa4442)'. Together they form a unique fingerprint.

Cite this